Michael Carroll

Michael Carroll

Ballard Spahr LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Third Circuit Denies Rehearing En Banc in Closely Watched Class Action

The U.S. Court of Appeals for the Third Circuit has denied a petition for rehearing en banc in a small-dollar consumer product class action. Depending on one’s perspective, this highly anticipated ruling either enforces the...more

5/6/2014 - Affidavits Bayer BMW Class Action En Banc Review

Federal Court Rejects Controversial Attempt To Expand Class Action Liability

In a putative class action in federal court, the U.S. District Court for the District of New Jersey quickly put to rest a controversial theory advanced by the plaintiffs to allow them to sue defendants who admittedly caused...more

4/21/2014 - Article III Class Action DirectTV Standing

Plaintiffs May Assert Negligent Design Claims for Prescription Drugs, Pa. Supreme Court Holds

In a stunning decision with broad implications for pharmaceutical companies in Pennsylvania and elsewhere, the Supreme Court of Pennsylvania has held that plaintiffs may assert negligence claims against pharmaceutical...more

1/24/2014 - FDA Negligence Negligent Design Pharmaceutical Prescription Drugs SCOTUS

Third Circuit Vacates Class Certification, Reaffirms Plaintiff’s Burden To Prove Readily Ascertainable Class

A recent decision by the U.S. Court of Appeals for the Third Circuit reaffirmed the importance of requiring a plaintiff in a class action to show there is a reliable and administratively feasible method for ascertaining who...more

8/14/2013 - Class Action Class Certification Wal-Mart Warranties

Third Circuit Vacates Class Certification, Reaffirms Plaintiff's Burden To Prove Readily Ascertainable Class

In Hayes v. Wal-Mart Stores, Inc., plaintiff alleged that Wal-Mart, through its retail warehouse Sam’s Club, violated the New Jersey Consumer Fraud Act, breached its contracts with consumers, and was unjustly enriched by...more

8/7/2013 - Breach of Contract Breach of Warranty Consumer Fraud Unjust Enrichment

Supreme Court Rejects ‘Stop-Selling’ Argument in Conflict Preemption Cases

In a 5-4 decision, the U.S. Supreme Court rejected the notion that a manufacturer’s option to stop selling its product resolves preemption concerns raised by conflicting state and federal laws....more

6/27/2013 - Generic Drugs Manufacturers Mutual Pharmaceuticals v Bartlett Preemption Prescription Drugs SCOTUS Stop-Selling Rationale

Federal Court Precludes Defendant’s Class Certification Expert

In a rare and cautionary opinion, the U.S. District Court for the District of New Jersey has precluded the testimony and report of an expert proffered by a defendant in opposition to certification in a consumer product class...more

3/7/2013 - Class Action Class Certification Daubert Hearing Expert Witness

7 Results
|
View per page
Page: of 1